• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of Community Health >Developing Profiles of Postmenopausal Women Being Prescribed Estrogen Therapy to Prevent Osteoporosis
【24h】

Developing Profiles of Postmenopausal Women Being Prescribed Estrogen Therapy to Prevent Osteoporosis

机译：绝经后妇女接受雌激素治疗以预防骨质疏松症的发展概况

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Postmenopausal women with estrogen deficiency are at high risk for osteoporosis. Estrogen therapy has been shown to be effective in preventing postmenopausal bone loss and maintaining bone mineral density. The increasing number of women at risk for osteoporosis and the high cost of treating this condition emphasizes the importance of preventing osteoporosis. This study was designed to identify trends and predictors of estrogen use for osteoporosis prevention among postmenopausal women. A retrospective, cross-sectional study was conducted using Behavioral Risk Factor Surveillance System data (1997–1999). Women 35 years and older who had passed menopause or were currently going through menopause were identified from the states including the BRFSS module that asked questions about estrogen use. Results showed an increasing prevalence in estrogen use from 1997 to 1999 for osteoporosis prevention. In 1999, almost a third of the postmenopausal women surveyed used estrogen to prevent osteoporosis. Prevalence was higher among women 45–64 years of age, whites, and those with higher education levels. Physician counseling on the benefits and risks of estrogen therapy was the strongest predictor of estrogen use for prevention of osteoporosis. Insurance coverage and compliance with other preventive behaviors such as mammograms and Pap smears were also strongly associated with greater estrogen use. However, women who were at risk for acute drinking, not married, overweight or obese, and diabetic were all less likely to receive estrogen therapy for osteoporosis prevention. The relationships demonstrated between estrogen use and demographic characteristics, lifestyle behaviors and health care access and utilization factors underline the importance of targeting specific groups of women for promoting its protective effect against osteoporosis.
机译：雌激素缺乏的绝经后妇女发生骨质疏松症的风险很高。已显示雌激素疗法可有效预防绝经后骨质流失并保持骨矿物质密度。面临骨质疏松症风险的妇女人数的增加以及治疗这种疾病的高昂费用强调了预防骨质疏松症的重要性。本研究旨在确定绝经后妇女预防骨质疏松症的雌激素使用趋势和预测因子。回顾性横断面研究使用行为危险因素监测系统数据（1997-1999）进行。从包括BRFSS模块在内的各州（包括询问雌激素使用问题的州）中识别出35岁及以上已过绝经或正在绝经的妇女。结果显示，从1997年至1999年，预防骨质疏松症的雌激素使用率上升。 1999年，接受调查的绝经后妇女中有近三分之一使用雌激素预防骨质疏松症。 45-64岁的女性，白人和受过高等教育的女性的患病率较高。有关雌激素治疗的益处和风险的医师咨询是预防骨质疏松症使用雌激素的最强预测指标。保险范围和对其他预防行为（如乳房X线照片和子宫颈抹片检查）的依从性也与大量使用雌激素密切相关。但是，有急性饮酒危险，未婚，超重或肥胖和糖尿病的妇女接受雌激素治疗预防骨质疏松症的可能性均较小。雌激素的使用与人口统计学特征，生活方式和健康护理获得与利用因素之间的关系表明，针对特定的女性群体以增强其对骨质疏松症的保护作用的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号